Posted by Michael Wonder on 26 Oct 2016
NHS drug suppliers investigated over prices
26 October 2016 - Competition watchdog launches investigation after claims prices of 32 drugs rose 1,000% in five years.
The competition watchdog has launched an investigation into drug companies accused of charging the NHS excessive prices.
If the companies are found by the the Competition and Markets Authority to have broken the law, they could face fines of up to 10% of their turnover.
The CMA said: “The investigation relates to suspected unfair pricing by way of charging excessive prices in the supply of certain pharmaceutical products, including to the National Health Service.”
The health secretary, Jeremy Hunt, called in the CMA in June after an investigation by the Times suggested companies were exploiting a loophole in NHS rules to raise prices of medicines.
